I don't get your statement: " ... A stock split would be a good way to pay back shareholders without paying tax ..."
A stock-split does absolutely nothing monetarily for the stockholder. The stock price will decrease (increase) proportionally to the increase (decrease) in the number of shares outstanding. On the other hand, a dividend would a monetary impact (a real return) to me.
read the interview with ceo heather bresch on Myl yahoo headlines. she doesn't persuade me that she is ready yet to run such a large enterprise.
also, chairman coury is of Lebanese descent. not sure this makes a difference, but an Israeli company potentiall run by a person of Arabic descent would probably privately raise shakles in the Israeli political higher-ups. but who knows?
I do believe that the generics portion of pharma is most likely to benefit from the future trends in the healthcare market.
how about this combo: Pfizer spins off its generic business just as it combines with mylan. norvartis's Sandoz also could be combined with mylan if the company wishes to bulk up its generic business.
Boss Talk in paper edition and online on October 9, 2013. Did anyone read the article? The CEO was asked about growing further Frontier and also about the a possible sale of the company. She mentioned that she had already been approached by a satellite company. She suggested an out-of-the-box transaction was possible.